Morclofone
Chemical compound
- R05DB25 (WHO)
- (4-chlorophenyl)-[3,5-dimethoxy-4-(2-morpholin-4-ylethoxy)phenyl]methanone
- 31848-01-8 Y
- 35949
- 33063 Y
- VY62TIB872
- D07395 Y
- DTXSID50185710
- Interactive image
- Clc1ccc(cc1)C(=O)c3cc(OC)c(OCCN2CCOCC2)c(OC)c3
InChI
- InChI=1S/C21H24ClNO5/c1-25-18-13-16(20(24)15-3-5-17(22)6-4-15)14-19(26-2)21(18)28-12-9-23-7-10-27-11-8-23/h3-6,13-14H,7-12H2,1-2H3 Y
- Key:KVCJCEKJKGLBOK-UHFFFAOYSA-N Y
Morclofone is a cough suppressant.[1]
References
- ^ Schenker H (April 1983). "[Efficacy of morclofon, a new synthetic antitussive agent, in geriatric patients. Results of a double-blind study]". Therapeutische Umschau. Revue Therapeutique. 40 (4): 358–61. PMID 6346561.
- v
- t
- e
Cough and cold preparations (R05)
- Althea root
- Ammonium chloride
- Antimony pentasulfide
- Cineole
- Creosote
- Guaiacolsulfonate
- Guaifenesin (+codeine, +hydrocodone, +oxomemazine)
- Hederae helicis folium
- Ipecacuanha (Syrup of ipecac)
- Levoverbenone
- Potassium iodide
- Senega
- Tyloxapol
- Acetylcysteine#
- Ambroxol
- Bromhexine
- Carbocisteine
- Dembrexine hydrochloride
- Domiodol
- Dornase alfa
- Eprazinone
- Erdosteine
- Letosteine
- Mannitol
- Mesna
- Neltenexine
- Sobrerol
- Stepronin
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e